Bicycle Therapeutics Stock Price on December 13, 2024
BCYC Stock | USD 14.55 0.05 0.34% |
Below is the normalized historical share price chart for Bicycle Therapeutics extending back to May 23, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Bicycle Therapeutics stands at 14.55, as last reported on the 30th of December, with the highest price reaching 14.85 and the lowest price hitting 14.25 during the day.
If you're considering investing in Bicycle Stock, it is important to understand the factors that can impact its price. Bicycle Therapeutics secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12% return per unit of standard deviation over the last 3 months. Bicycle Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bicycle Therapeutics' mean deviation of 2.44, and Risk Adjusted Performance of (0.09) to double-check the risk estimate we provide.
At present, Bicycle Therapeutics' Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 927.6 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 23.1 M. . At present, Bicycle Therapeutics' Price Sales Ratio is projected to decrease significantly based on the last few years of reporting. Bicycle Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 23rd of May 2019 | 200 Day MA 22.5748 | 50 Day MA 20.972 | Beta 0.892 |
Bicycle |
Sharpe Ratio = -0.1181
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | BCYC |
Estimated Market Risk
4.82 actual daily | 42 58% of assets are more volatile |
Expected Return
-0.57 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bicycle Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bicycle Therapeutics by adding Bicycle Therapeutics to a well-diversified portfolio.
Price Book 1.2089 | Enterprise Value Ebitda (2.14) | Price Sales 27.2269 | Shares Float 1.9 M | Wall Street Target Price 33.3636 |
Bicycle Therapeutics Main Headline on 13th of December 2024
Were Hopeful That Bicycle Therapeutics Will Use Its Cash Wis... by finance.yahoo.com
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Bicycle Therapeutics Valuation on December 13, 2024
It is possible to determine the worth of Bicycle Therapeutics on a given historical date. On December 13, 2024 Bicycle was worth 17.29 at the beginning of the trading date compared to the closed value of 13.81. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bicycle Therapeutics stock. Still, in general, we apply an absolute valuation method to find Bicycle Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bicycle Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bicycle Therapeutics' related companies.
Open | High | Low | Close | Volume | |
20.87 | 21.14 | 20.11 | 20.11 | 307,893 | |
12/13/2024 | 17.29 | 17.78 | 12.17 | 13.81 | 5,713,477 |
13.88 | 15.72 | 13.88 | 15.12 | 1,964,567 |
Backtest Bicycle Therapeutics | | | Bicycle Therapeutics History | | | Bicycle Therapeutics Valuation | Previous | Next |
Bicycle Therapeutics Trading Date Momentum on December 13, 2024
On December 16 2024 Bicycle Therapeutics was traded for 15.12 at the closing time. The top price for the day was 15.72 and the lowest listed price was 13.88 . The trading volume for the day was 2 M. The trading history from December 16, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 9.49% . The overall trading delta against the current closing price is 7.17% . |
Bicycle Therapeutics Fundamentals Correlations and Trends
By evaluating Bicycle Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Bicycle Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Bicycle financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Bicycle Therapeutics Stock history
Bicycle Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bicycle is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bicycle Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bicycle Therapeutics stock prices may prove useful in developing a viable investing in Bicycle Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 35.6 M | 23.1 M | |
Net Loss | -101.4 M | -96.4 M |
Bicycle Therapeutics Quarterly Net Working Capital |
|
Bicycle Therapeutics Stock Technical Analysis
Bicycle Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Bicycle Therapeutics Period Price Range
Low | December 30, 2024
| High |
0.00 | 0.00 |
Bicycle Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Bicycle Therapeutics December 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Bicycle Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bicycle Therapeutics shares will generate the highest return on investment. By undertsting and applying Bicycle Therapeutics stock market strength indicators, traders can identify Bicycle Therapeutics entry and exit signals to maximize returns
Bicycle Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Bicycle Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Bicycle Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bicycle to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.09) | |||
Jensen Alpha | (0.60) | |||
Total Risk Alpha | (0.73) | |||
Treynor Ratio | (1.71) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Bicycle Stock analysis
When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |